Company Overview of Agios Pharmaceuticals, Inc.
Key Executives for Agios Pharmaceuticals, Inc.
|David P. Schenkein M.D.||54 Relationships||Chief Executive Officer, President and Director||59|
|Lewis Clayton Cantley Ph.D.||69 Relationships||Co-Founder, Director, Member of Scientific Advisory Board and Chairman of Science & Technology Committee||67|
|Tak Wah Mak Ph.D., D.Sc.,FRSC||155 Relationships||Co-Founder and Member of Scientific Advisory Board||70|
|Craig B. Thompson M.D.||131 Relationships||Co-Founder and Chairman of Scientific Advisory Board||63|
|Andrew Hirsch||12 Relationships||Chief Financial Officer||45|
|View More Key Executives|
Agios Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|John M. Maraganore M.D., Ph.D.||169 Relationships||Alnylam Pharmaceuticals, Inc.||53|
|David P. Schenkein M.D.||54 Relationships||Agios Pharmaceuticals, Inc.||59|
|Lewis Clayton Cantley Ph.D.||69 Relationships||Agios Pharmaceuticals, Inc.||67|
|Tak Wah Mak Ph.D., D.Sc.,FRSC||155 Relationships||Agios Pharmaceuticals, Inc.||70|
|Craig B. Thompson M.D.||131 Relationships||Agios Pharmaceuticals, Inc.||63|
Agios Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee M.B.A.||Paul J. Clancy||21 Relationships||3 Executives|
|Compensation Committee||Kaye I. Foster-Cheek||39 Relationships||3 Executives|
|Nominating Committee||Kaye I. Foster-Cheek||39 Relationships||3 Executives|
|Corporate Governance Committee||Kaye I. Foster-Cheek||39 Relationships||3 Executives|
|Advisory Board M.D.||Craig B. Thompson||131 Relationships||9 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation||$54.6M|
|Total Value of Options||$517.5K|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.